NERV insider transaction filings
Minerva Neurosciences, Inc. — 26 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-03. Screen NERV transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 1 Form 4 filing. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Kaul Inderjit — Director | 1 | — | — | 1 |
Recent Form 4 filings — Minerva Neurosciences, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-03 | 4 | Kaul Inderjit — Director | Grant/award (A): 12,147 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Kaul Inderjit — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Kupfer David — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Laghrissi-Thode Fouzia — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Luthringer Remy — CEO, Director | Grant/award (A): 1,690,700 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Ahlholm Frederick W — SVP, CFO and Secretary | Grant/award (A): 680,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | HASLER HANS PETER — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | VAN HEEK G JAN — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | O'Connor James Joseph — Chief Business Officer and GC | Grant/award (A): 350,800 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Kaul Inderjit — Director | Grant/award (A): 12,169 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Kaul Inderjit — Director | Grant/award (A): 364,504 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Kupfer David — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Laghrissi-Thode Fouzia — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Luthringer Remy — CEO, Director | Grant/award (A): 2,250,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Race Geoff — President | Grant/award (A): 1,500,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Ahlholm Frederick W — SVP, CFO and Secretary | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | HASLER HANS PETER — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | VAN HEEK G JAN — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Kaul Inderjit — Director | Grant/award (A): 9,500 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | Laghrissi-Thode Fouzia — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | Kupfer David — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | Race Geoff — President | Grant/award (A): 95,000 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | Luthringer Remy — CEO, Director | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | Ahlholm Frederick W — SVP, CFO and Secretary | Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | HASLER HANS PETER — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | VAN HEEK G JAN — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — Minerva Neurosciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-06 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-04-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-03 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events | EDGAR |
| 2025-12-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NERV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →